Kathryn M. Duesman
2021
In 2021, Kathryn M. Duesman earned a total compensation of $320.8K as Vice President of Clinical Affairs at Retractable Technologies, a 13% increase compared to previous year.
Compensation breakdown
Bonus | $124,767 |
---|---|
Salary | $192,156 |
Other | $3,841 |
Total | $320,764 |
Duesman received $192.2K in salary, accounting for 60% of the total pay in 2021.
Duesman also received $124.8K in bonus and $3.8K in other compensation.
Rankings
In 2021, Kathryn M. Duesman's compensation ranked 11,532nd out of 12,415 executives tracked by ExecPay. In other words, Duesman earned more than 7.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 11,532 out of 12,415 | 7th |
Division Manufacturing | 5,078 out of 5,508 | 8th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 717 out of 801 | 11th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 469 out of 522 | 10th |
Industry Surgical and Medical Instruments and Apparatus | 297 out of 327 | 9th |
Source: SEC filing on March 31, 2022.
Duesman's colleagues
We found four more compensation records of executives who worked with Kathryn M. Duesman at Retractable Technologies in 2021.
News
Retractable Technologies CEO Thomas Shaw's 2023 pay rises 7% to $1.1M
March 29, 2024
Retractable Technologies CEO Thomas Shaw's 2022 pay falls 91% to $1.1M
March 30, 2023
Retractable Technologies CEO Thomas Shaw's 2021 pay jumps 2,129% to $12M
March 31, 2022
Retractable Technologies CEO Thomas Shaw's 2020 pay rises 2% to $517K
March 31, 2021
Retractable Technologies CEO Thomas Shaw's 2019 pay rises 2% to $505K
March 30, 2020
Retractable Technologies CEO Thomas Shaw's 2018 pay rises 3% to $496K
March 28, 2019